About half of human genes use alternative cleavage and polyadenylation (ApA) to generate mRNA transcripts that differ in the length of their 3' untranslated regions (3'UTRs) while producing the same protein 1-3 . Here we show in human cell lines that alternative 3' UTRs differentially regulate the localization of membrane proteins. The long 3'UTR of CD47 enables efficient cell surface expression of CD47 protein, whereas the short 3'UTR primarily localizes CD47 protein to the endoplasmic reticulum. CD47 protein localization occurs post-translationally and independently of RNA localization. In our model of 3' UTR-dependent protein localization, the long 3' UTR of CD47 acts as a scaffold to recruit a protein complex containing the RNAbinding protein HuR (also known as ELAVL1) and SET 4 to the site of translation. This facilitates interaction of SET with the newly translated cytoplasmic domains of CD47 and results in subsequent translocation of CD47 to the plasma membrane via activated RAC1 5 . We also show that CD47 protein has different functions depending on whether it was generated by the short or long 3'UTR isoforms. Thus, ApA contributes to the functional diversity of the proteome without changing the amino acid sequence. 3' UTR-dependent protein localization has the potential to be a widespread trafficking mechanism for membrane proteins because HuR binds to thousands of mRNAs 6-9 , and we show that the long 3' UTRs of CD44, ITGA1 and TNFRSF13C, which are bound by HuR, increase surface protein expression compared to their corresponding short 3' UTRs. We propose that during translation the scaffold function of 3' UTRs facilitates binding of proteins to nascent proteins to direct their transport or function-and that this role of 3' UTRs can be regulated by ApA.
CD47 is best known as a ubiquitous cell surface molecule that acts as a marker of self and protects cells from phagocytosis by macrophages 11, 12 . We found CD47 protein expressed on the cell surface as well as intracellularly ( Fig. 1a and Extended Data Fig. 1a-c) . The CD47 gene produces alternative 3' UTRs as determined by the 3'-end sequencing method 3'-seq and confirmed by northern blot analysis (Fig. 1b, c) 3 . Exclusive knockdown of the longer 3'UTR isoform by short hairpin RNAs (shRNAs) decreased CD47 surface expression without changing intracellular expression ( Fig. 1d and Extended Data Fig. 1d-g ). This suggests that the long 3'UTR isoform facilitates cell surface localization of CD47 protein.
To test this hypothesis, we asked whether green fluorescent protein (GFP) encoded by an mRNA containing the long (with a mutated proximal polyadenylation signal; Extended Data Fig. 1h ) or the short 3'UTR of CD47 would localize differently. To allow GFP to enter the secretory pathway, we replaced the extracellular domain (ECD) of CD47 with GFP, while preserving the CD47 signal peptide, transmembrane domains (TMDs) and C-terminus, which we refer to as GFP-TM (Fig. 1e) . We observed that GFP-TM encoded by an mRNA containing the long 3'UTR of CD47 (GFP-TM-LU) localizes primarily to the cell surface whereas GFP-TM encoded by an mRNA with the short 3'UTR of CD47 (GFP-TM-SU) localizes predominantly to the endoplasmic reticulum ( Fig. 1f and Extended Data Fig. 1i ). The localization results were confirmed by fluorescence-activated cell sorting (FACS) analysis, using an anti-GFP antibody on permeabilized and non-permeabilized cells to measure total and surface GFP levels, respectively (Fig. 1g) . The localization step occurs at the protein level, as both the LU-and SU-containing GFP transcripts show a similar distribution near the perinuclear ER (Fig. 1h) . Thus the LU isoform of CD47 encodes information that is necessary for cell surface expression of GFP-TM protein, in a manner independent of RNA localization.
To address the mechanism of 3'UTR-dependent protein localization (UDPL; Fig. 2a ), we reasoned there must be an RNA-binding protein (RBP) that binds to the long, but not the short, 3'UTR of CD47. The long 3'UTR of CD47 contains many uridine-rich elements (see later) which are potentially bound by HuR [6] [7] [8] [9] . HuR is known for its role in mRNA stabilization and translation activation 7, 13, 14 . However, HuR KD by shRNAs did not affect CD47 mRNA abundance or isoform levels, nor did it affect total CD47 protein levels ( Beyond the role of HuR as an RBP [6] [7] [8] [9] , HuR interacts through protein-protein interactions with SET, ANP32A and ANP32B 4 . Nuclear SET binds to histone tails and prevents acetylation 15 , but phosphorylated SET localizes to the cytoplasm and the surface of the endoplasmic reticulum 5, 16 . Also, SET interacts with RAC1, and active RAC1 translocates SET to the plasma membrane 5 . In our model of UDPL (Fig. 2a) , HuR binds to the long 3'UTR of CD47 and recruits SET. Upon targeting of the mRNA to the ER surface, the scaffold function of the 3'UTR results in local recruitment of SET to the site of translation. After translation of CD47 mRNA, the ECD is located in the ER lumen, whereas its Cterminus is cytoplasmic. This allows SET to interact with the newly translated cytoplasmic domains of CD47 and to translocate CD47 to the plasma membrane via active Rac1.
Transfer of SET from CD47 mRNA to CD47 protein likely requires energy input, as has been shown for transfer of the signal peptide from the signal recognition particle to the translocation channel 17 . In this model of UDPL, surface expression of CD47-LU depends on SET and active RAC1. And indeed, knockdown of SET or RAC1 by shRNAs reduced surface expression of CD47 without affecting overall CD47 levels ( Fig. 2b and Extended Data Fig. 2c-e) .
To determine if UDPL is a more widespread phenomenon, we examined the localization of four additional transmembrane proteins which are derived from mRNAs with 3'UTR isoforms that can be bound by HuR [6] [7] [8] (Extended Data Fig. 3, 4) . TSPAN13 has only one 3'UTR isoform, whereas the other three genes [CD44, ITGA1, TNFRSF13C (encoding BAFF receptor, BAFFR)] use ApA to generate alternative 3'UTR isoforms ( Fig. 2c and Extended Data Fig. 2a, f) 3 . As was the case for CD47, KD of HuR decreased surface expression of all four proteins without changing total protein levels ( Fig. 2c and Extended Data Fig. 2f ). As was done for CD47, we generated GFP-fused LU and SU constructs for CD44, ITGA1, and TNFRSF13C with their respective TMDs, C-termini and 3'UTRs. For all tested genes, the longer 3'UTR increased surface localization of GFP-TM ( Fig. 1f-h, 2d and Extended Data Fig. 2g ). This demonstrates that UDPL has the potential to be a widespread phenomenon.
The 3' UTR of CD47 contains over 30 putative HuR-binding sites (Extended Data Fig. 3) . We tested whether a 3'UTR with a few HuR-binding sites (HuR-BS) (Extended Data Fig. 3 ) is enough to mediate surface localization. Indeed, the uridine-rich sequence was necessary and sufficient for surface localization of GFP-TM, although it was less potent than the fulllength 3'UTR of CD47 (Fig. 2e) .
Next, we investigated each step of our UDPL model in more detail. We demonstrated by RNA immunoprecipitation (RNA-IP) that HuR binds to the HuR-BS and to the LU but not to the SU isoform of CD47 (Fig. 3a, left) . SET also associates with the long 3'UTR of CD47, which is dependent on HuR (Fig. 3a, right) . SET or HuR overexpression was insufficient to localize GFP-TM-SU to the cell surface (Extended Data Fig. 5a, b) . However, tethering of SET or HuR to the short 3'UTR isoform of CD47 was sufficient to redirect GFP-TM localization from the ER to the plasma membrane ( Fig. 3b and Extended Data Fig. 5c, d ; see Extended Data Fig. 5 for experimental details). This indicates that local recruitment of SET to the site of translation, mediated by the scaffold function of the long 3'UTR, is required for UDPL.
Furthermore, by co-immunoprecipitation we demonstrated that endogenous SET only interacts with CD47-LU protein, but not with CD47-SU protein (Fig. 3c) . Since SET binds to lysine residues 18 , we mutated single lysines in the C-terminus of CD47 which decreased GFP-TM surface localization by up to 37% (Extended Data Fig. 6a ). Mutation of 2/5 lysines decreased it by more than 50% and deletion of the entire C-terminus decreased it by 80% (GFP-TM-LUΔC; Fig. 3d and Extended Data Fig. 6b ). Additional mutation of three lysines in the first cytoplasmic loop abolished surface GFP expression (GFP-TM-LUΔCL; Fig. 3d and Extended Data Fig. 6b ). The reduction in surface expression is likely due to partial or complete loss of SET binding to CD47, as demonstrated by co-IP (Fig. 3e) .
To test if the difference in surface localization has phenotypic consequences, we added the ECD of CD47 to the GFP constructs (called CD47-LU or CD47-SU; Fig. 4a ). Both constructs resulted in comparable overall CD47 protein levels (Extended Data Fig. 7a ). CD47-LU efficiently localized to the cell surface via UDPL mediated by active RAC1 (Fig.  4b, c and Extended Data Fig. 7b ). Whereas GFP expressed from the GFP-TM-SU construct nearly completely localized to the endoplasmic reticulum (Fig. 1f-h ), CD47-SU primarily localizes to the endoplasmic reticulum, but also localizes partially to the cell surface, but independently of active RAC1 (Fig. 4b, c) .
We added the respective ECDs to CD44 and BAFFR, which also increased surface expression of their SU isoforms compared with their GFP-TM isoforms, but to a lesser extent than was observed for CD47 (Extended Data Fig. 7c, d) . Di-or multimerization of cell surface receptor subunits, which often occurs through their ECDs, is a common strategy for overcoming ER retention, because it results in masking of ER retention signals 19 . We speculate that CD47-SU, CD44-SU and BAFFR-SU might use such a mechanism (though the multimerization partners are unknown) for their partial surface expression. In the case of BAFFR the ECD only increased surface expression by 1.2-fold indicating that BAFFR strongly depends on UDPL for surface expression (Extended Data Fig. 7d ). This is supported by the absence of BAFFR on B cells in Rac-deficient mice 20 . Taken together, our data suggests that membrane proteins rely on UDPL for surface expression to varying degrees.
Cells with high CD47 surface levels are protected from phagocytosis by macrophages (Extended Data Fig. 7e ) 12 . To examine if the difference in surface expression of CD47-LU and CD47-SU protects cells to a different extent from phagocytosis, we used CD47-deficient Jurkat cells (called JinB8 cells 21 ) and expressed similar total amounts of CD47-LU or CD47-SU (Extended Data Fig. 7a ). Co-culture of these cells with macrophages demonstrated that CD47-LU fully protected the cells, whereas CD47-SU only partially protected the cells from phagocytosis (Fig. 4d ).
CD47 also functions in the regulation of apoptosis 22 , as JinB8 cells or tissues from Cd47 knock-out mice 23 fail to undergo apoptosis after γ-irradiation 24, 25 . Interestingly, expression of CD47-SU in JinB8 cells restored apoptosis, but expression of CD47-LU did not affect the loss-of-apoptosis phenotype ( Fig. 4e and Extended Data Fig. 7f, g ). Thus, when a cell requires increased CD47 surface expression, transcriptional upregulation alone would be non-optimal as it would confer increased susceptibility to apoptosis. ApA-generated 3'UTR isoforms allow independent regulation of differentially localized and functionally distinct CD47 protein.
As the surface localization of CD47-SU is RAC1-independent, it also does not co-localize with RAC1 at the plasma membrane (Fig. 4f) . In contrast, CD47-LU shows strong colocalization with RAC1 at lamellipodia (Fig. 4f) . Both activated RAC1 and CD47 are necessary for efficient cell migration and activated RAC1 localizes to the leading edge of migrating cells 5, 23, 26 . We show that only the expression of CD47-LU resulted in changes in cell morphology with the generation of lamellipodia at the leading edge of cells. Furthermore, CD47-LU, but not CD47-SU resulted in increased active RAC1 (Fig. 4g) which suggests that CD47-LU may cooperate with RAC1 during cell migration. Thus, CD47 protein localized to the same cellular compartment, but produced by the SU or LU mRNA isoforms, can exert different functions. It is currently not known if other surface proteins derived from their LU or SU isoforms also have distinct biological roles.
We propose that UDPL is a widespread mechanism for surface expression of membrane proteins. All currently known components of the pathway (HuR, SET and RAC1) are ubiquitously and highly expressed (Extended Data Fig. 8a) 3 . UDPL requires the presence of HuR-binding sites in the 3'UTR and SET-binding sites in the cytoplasmic domains of membrane proteins (Extended Data Figs 3, 4 and 9 ). All candidates tested so far that met both requirements used UDPL for surface expression (Figs 1f-h, 2d, 4b and Extended Data Figs 2g, 7c). HuR-binding sites are highly abundant as HuR binds to thousands of mRNAs [6] [7] [8] [9] , with a third of them being membrane proteins (Extended Data Fig. 8b ). Although the SET-binding motif is currently unknown, we (Fig. 3d, e and Extended Data Fig. 6 ) and others have shown that SET binds to positively charged amino acids in histone tails or cytoplasmic domains of membrane proteins 18, 27 . According to the positive-inside rule for integral membrane proteins, the cytoplasmic domains of membrane proteins are enriched in positively charged amino acids for topological reasons 28 . Therefore, potential SET-BS in cytoplasmic domains of membrane proteins are very widespread.
So far, efforts to determine the consequences of alternative 3'UTRs have largely focused on mRNA stability and translation 1, 2, 29 . We expand the known functions of 39UTRs and show that they can act as scaffolds for RBPs that serve as adaptors to recruit effector proteins to the site of translation, which determines subcellular protein localization and function. With respect to CD47, CD44, ITGA1, TSPAN13 and BAFFR, the adaptor protein is HuR and the effector protein is SET. We further speculate that the scaffold function of 3'UTRs may extend beyond the regulation of membrane proteins. RBPs could recruit other effector proteins, for example, enzymes that post-translationally modify proteins, as was shown for long non-coding RNAs 30 . We showed here that CD47 produced by alternative 3'UTR isoforms localizes to different cellular compartments and has independent and sometimes opposite functions with respect to cell survival and cell migration. Thus, through generation of alternative 3'UTR isoforms, ApA contributes to functional diversity of the proteome without changing the amino acid sequence.
Online Methods

Cell lines
MCF7 (breast cancer), HeLa (cervical cancer), HEK293 (embryonic kidney), Caov-3 (ovarian carcinoma), NTERA2 (embryonic carcinoma) and THP-1 cells (monocytic leukemia) were purchased from ATCC. B-LCL are Epstein Barr virus (EBV)-immortalized human B cells described earlier 3 . U2OS cells (sarcoma) were a gift from Thijn Brummelkamp (Netherlands Cancer Institute, Netherlands), Toledo (B cell lymphoma) cells were a gift from Markus Mueschen (UCSF), U251 (glioblastoma) cells were a gift from Ingo Mellinghoff (MSKCC), SHSY-5Y (neuroblastoma) cells were a gift from Thomas Tuschl (Rockefeller University) and Jurkat (T cell leukemia) and JinB8 (CD47-negative Jurkat) cells were a gift from William Frazier (Washington University).
Constructs
For some of the shRNA knockdown experiments, pSUPERretropuro was modified by cloning IRES::GFP (derived from pMSCVpig) 2 downstream of puromycin in order to obtain pSUPERretropuro containing enhanced (e)GFP (shRNA-GFP). The following DNA oligonucleotides served as shRNA precursors and were cloned into pSUPER-GFP or pSUPER:
The sequence of shRNA1 SET and of shRNA Control were published earlier 31, 32 . The GFP-fusion constructs were generated in pcDNA3.1 expression vector (Life Technologies). The short and long 3'UTRs of CD47 were PCR-amplified from genomic DNA using Q5 High Fidelity DNA polymerase (NEB) and the primers listed below and inserted between the NotI and XbaI sites. To obtain expression of only the long 3'UTR isoform of CD47, the proximal polyadenylation site was mutated from AAUAAA to ACUCAA using the QuikChange Multi Site Directed Mutagenesis Kit (Agilent). The resulting plasmids were used to test qPCR primers for accuracy in measuring short to long 3'UTR isoform ratios (see later). The short 3'UTR of CD47 used in the MS2-BS construct was cloned from the plasmid containing the long 3'UTR with the mutated proximal polyadenylation site. eGFP was PCRamplified from pMSCV-pig and inserted upstream of each CD47 3'UTR (BamHI, NotI). The signal peptide of CD47 was generated by annealing two DNA oligonucleotides which were inserted into the BamHI site. To generate the GFP-TM constructs, the sequence of the TMDs and C-terminal tail of CD47 (the longest isoform, isoform 4 33 ) were cloned from Toledo cDNA and inserted downstream of eGFP (BsrgI, NotI). Isoform 4 was chosen as it is the most abundant isoform in Jurkat cells (data not shown). The two nucleotides of eGFP that occur after the BsrgI site were included in the forward primer. To generate the GFP-CD47 constructs, the ECD, TMDs and C-terminus of CD47 were PCR-amplified from Toledo cDNA using the TM reverse primer and the CDS forward primer and inserted downstream of eGFP (BsrgI, NotI). The sequence of HuR-BS and HuR-BSΔ are shown in Extended Data Fig. 3 and replaced the long 3'UTR in GFP-TM-LU. The GFP constructs containing the TMDs and C-termini fused to either the long or short 3'UTRs of CD44, ITGA1, and TNFRSF13C were generated as follows. TMDs, C-termini and short 3'UTRs of CD44, ITGA1 and TNFRSF13C were cloned from Toledo, SHSY-5Y and B-LCL cDNA respectively and inserted downstream of eGFP (BsrgI, XbaI). Short 3'UTRs consisted of the first 122 nucleotides of CD44, the first 45 nucleotides of ITGA1 and the first 337 nucleotides of TNFRSF13C. Long 3'UTRs: 3068 nucleotides after the stop codon of CD44 and 3996 nucleotides after the stop codon of ITGA1 were used. For TNFRSF13C , 1221 nucleotides after the stop codon together with the last 600 nucleotides of the 3'UTR (nucleotides 2712 -3311 after the stop codon containing the majority of HuR-binding sites) were used as long 3'UTR and were cloned from genomic DNA. To generate BAFFR-SU and -LU, the complete open reading frame of TNFRSF13C (without the start codon) was amplified from human B cell cDNA and cloned using Gibson Assembly Cloning (NEB) into pcDNA3.1 vector used above downstream of eGFP. To generate CD44-SU and -LU, the open reading frame of CD44 (without the start codon) was amplified from cDNA of the human breast cancer cell line MDA-MB231 and cloned using Gibson Assembly Cloning (NEB) into pcDNA3.1 vector used above downstream of eGFP. To generate the GFP-TM-LUΔC construct the sequence of just the TMDs of CD47 was cloned from Toledo cDNA using the TM forward primer and TMΔC reverse primer and inserted downstream of eGFP (BsrgI, NotI). The 24 MS2-binding sites were cloned from a plasmid obtained from Jeffrey Gerst (Weizman Institute) 34 using the primers listed below (XbaI, ApaI). The constructs in which K163, K166, K175, K290, K297 and K304 were mutated to alanines were generated using the QuikChange Multi Site Directed Mutagenesis Kit (Agilent). To create the MS2 fusion constructs 35 , the pUG34-MS2-GFP-SBP plasmid was obtained from Jeffrey Gerst 34 . SBP was replaced by either HuR, SET or a stop codon. HuR and SET were PCR-amplified from U2OS cDNA using the primers listed below (BsrgI, XbaI). The stop codon was generated by annealing two DNA oligonucleotides (BsrgI, XbaI). mCherry was PCR-amplified and replaced GFP (BamHI, BsrgI). After cloning was complete, all plasmids were sequenced to assure fidelity of the sequences. The N17RAC1 construct was provided by Alan Hall (MSKCC) 36 .
Transfections
For transfections into U2OS, HEK293, HeLa and U251 cells Lipofectamine 2000 (Invitrogen) and for SHSY-5Y cells Xtreme reagent (Roche) was used. JinB8 and Jurkat cells were transfected using the Neon Transfection System (Invitrogen) according to the manufacturer's protocol for transfecting Jurkat cells. To account for differences in the sizes of transfected plasmids the same molar amounts were transfected. When RNA was to be extracted, the cells were grown in the presence of high amounts of puromycin (4 mg/ml) for three days and FACS analysis was performed to ensure that >90% of the cells were GFP+.
Generation of cell lines with stable expression of shRNAs
Stable cell lines were generated as described previously 2 .
FACS analysis
For surface FACS (in order to detect surface protein expression), cells were incubated with mouse anti-CD47-PerCy5.5 (BD Biosciences, 561261), mouse anti-CD44-PE (BD Biosciences, 561858), chicken anti-GFP (Abcam, ab13970), mouse anti-ITGA1-PE (BD Biosciences, 555749), mouse anti-BAFFR-PE (BD Biosciences, 554680) or rabbit anti-TSPAN13 (Genetex, GTX52155) in FACS buffer A (0.5% FBS in PBS) for 30 minutes at 4°C, and then washed twice in FACS Buffer A. For detection of GFP and TSPAN13, cells were then incubated with goat anti-chicken alexa fluor 568 (Invitrogen, A11041) and goat anti-rabbit alexa fluor 680 (Invitrogen, A-21076) respectively, for 30 minutes at 4°C, and then washed twice in FACS Buffer A. At least 30,000 cells were analyzed on a BD FACSCalibur cell analyzer (BD Biosciences) and FACS data was computed using the FlowJo VX software.
For intracellular FACS (in order to detect total protein expression), cells were fixed for 15 minutes at room temperature (RT) in fixation buffer (4% PFA, 0.02% sodium azide, and 0.1% Tween 20 in PBS), washed in FACS buffer B (0.02% sodium azide, 0.1% Tween 20 in PBS), permeabilized for 10 minutes at 4°C in permeabilization buffer (0.02% sodium azide, 0.1% Tween 20 and 10% dimethyl sulfoxide in PBS), washed, re-fixed for 5 minutes at RT in fixation buffer, and washed again. Cells were incubated with the same primary and secondary antibodies as for surface FACS in FACS buffer B for 30 minutes at 4°C, and then washed twice in FACS Buffer B. For live/dead analysis by FACS, cells were incubated with TO-PRO3 in FACS buffer A (0.5% FBS in PBS) for 10 minutes at 4°C, and then washed twice in FACS Buffer A. Cells were analyzed is the same manner as for surface FACS.
For all the GFP expressing plasmids the 20% of cells with the highest GFP expression are shown.
Immunocytochemistry
For surface staining of CD47, cells were fixed for 15 minutes at RT in fixation buffer A (4% PFA and 0.02% sodium azide in PBS), washed with PBS, blocked for 15 minutes at 4°C in 5% Normal Goat Serum (Invitrogen, PCN5000) in PBS and then incubated with mouse antihuman CD47 (Santa Cruz, sc-59079) primary antibody for 1 hour at 4°C in PBS. Following washing in PBS, donkey anti-mouse alexa fluor 594 (Invitrogen, A-21203) secondary antibody was incubated for 1 hour at 4°C in PBS, and during the last 10 minutes of incubation DAPI (Invitrogen, D1306) was added, followed by three washes of PBS. Mowiol mounting media (Sloan Kettering Institute, Molecular Cytology Core Facility) was used to mount the slides. Imaging was performed at the Sloan Kettering Institute Molecular Cytology Core Facility, on a Leica TCS SP5 confocal microscope, using a 63x, 1.4 numerical aperture oil objective.
For intracellular staining of CD47, cells were fixed for 15 minutes at RT in fixation buffer B (4% PFA, 0.02% sodium azide, and 0.1% Tween 20 in PBS), washed in wash buffer (0.02% sodium azide, 0.1% Tween 20 in PBS), permeabilized for 10 minutes at 4°C in permeabilization buffer (0.02% sodium azide, 0.1% Tween 20 and 10% dimethyl sulfoxide in PBS), washed, re-fixed for 5 minutes at RT in fixation buffer B, washed and blocked for 15 minutes at 4°C in 5% Normal Goat Serum in wash buffer. Mouse anti-CD47 (Santa Cruz, sc-59079) primary antibody was incubated overnight at 4°C in wash buffer. The strong permeabilization and overnight staining were necessary to visualize intracellular CD47, as the CD47 antibody recognizes an epitope in the ECD of CD47 which is located in the lumen of the ER. Due to the extended treatment with a buffer containing Tween 20 the plasma membrane could no longer be visualized in these cells.
For co-staining of GFP with Calnexin or RAC1, the cells were fixed for 15 minutes at RT in fixation buffer B (4% PFA, 0.02% sodium azide, and 0.1% Tween 20 in PBS), washed with wash buffer B, blocked for 15 minutes at 4°C in 5% Normal Goat Serum (Invitrogen, PCN5000) in wash buffer and then incubated with rabbit anti-Calnexin (Santa Cruz, sc-11397) or mouse anti-RAC1 (Abcam, ab12048) primary antibodies for 1 hour at 4°C in wash buffer. Following washing, goat anti-rabbit alexa fluor 680 (Invitrogen, A-21076) or donkey anti-mouse alexa fluor 594 (Invitrogen, A-21203) secondary antibodies were incubated for 1 hour at 4°C in wash buffer, and during the last 10 minutes of incubation DAPI (Invitrogen, D1306) was added, followed by three washes. Mounting and imaging was performed as for the surface staining. Due to the lack of permeabilization and short period in Tween 20, the plasma membrane was still visible. When Calnexin was co-stained with endogenous CD47, the protocol for intracellular staining of CD47 was used and the plasma membrane was again not visible.
Alexa fluor 594 and 680 were pseudo-colored red and endogenous GFP and mCherry were imaged as they appear, without any antibody.
RNA-FISH
Custom Stellaris FISH Probes (Biosearch Technologies) were designed for the open reading frame of eGFP using the Stellaris Probe designer website, and with the assistance of Biosearch Technologies staff. The probes were conjugated to the Quasar 670 fluorochrome. Staining was carried out according to the manufacturer's protocols. Briefly, 24 hours after transfection of the GFP-TM constructs cells were trypsinized and plated on Millicell EZ glass slides (Millipore) and allowed to grow over night. Cells were washed in PBS, fixed in 4% PFA at RT for 10 minutes and permeabilized in 70% ethanol at 4°C for 2 hours. Following washing, the probes were hybridized at 37°C for 4 hours, washed, incubated with DAPI at 37°C for 30 minutes, washed and mounted in Mowiol mounting media. Imaging was performed as for the surface immunostaining. RNA was pseudo-colored red, and GFP was imaged as it appears, without any antibody.
3'-seq
3'-seq reads of naïve B cells, B-LCL and HEK293 cells were analyzed and visualized as described previously 3 .
Northern Blot analysis
Northern blots were performed as previously described 2 .
CD47 probe F: 5'-TTGATGGAGCTCTAAACAAGTCC-3'; CD47 probe R: 5'-GAATAACCAATATGGCAATGACG-3'; GFP probe F: 5'-TAAACGGCCACAAGTTCAGC-3'; GFP probe R: 5'-CTTGTACAGCTCGTCCATGC-3'
Quantitative PCR
RNA was extracted using TRI Reagent (Ambion) according to the manufacturer's protocol. cDNA was synthesized using random hexamers and the TaqMan Reverse Transcription Kit (Applied Biosystems). qRT-PCR was performed using the Power SYBR Green master mix (Applied Biosystems) on a 7500 HT Fast Real-Time PCR System (Applied Biosystems). Each reaction was performed in triplicate. The experiments were performed at least three times to obtain at least three biological replicates. The following primers were used to quantify total CD47 mRNA, the long 3'UTR isoform of CD47 and GAPDH for normalization.
CD47TotalF: 5'-AGTGATGGACTCCGATTTGG-3'; CD47TotalR: 5'-GGGTCTCATAGGTGACAACCA-3'; CD47LongF: 5'-AAGAGAACTCCAGTGTTGCT-3'; CD47LongR: 5'-ACGGTAACACAGCTGTAAAACA-3'; GAPDHF: 5'-ACAACTTTGGTATCGTGGAAGG-3'; GAPDHR: 5'-TATTTGGCAGGTTTTTCTAGACG-3'
To measure 3'UTR isoform expression by qRT-PCR and to take into account different affinities of primers, we generated a standard using plasmids that contained either the short or the long 3'UTR of CD47 (see earlier). We mixed together known quantities of the two plasmids ranging from 3:1 to 1:3 of short to long 3'UTR and performed qPCR on these mixtures to test the accuracy of our primer sets. The fraction of the long 3'UTR isoform corresponds to the 2 CT difference. The log2 value of the CT difference corresponds to the fraction of the long 3'UTR isoform. The fraction of the short 3'UTR isoform was obtained by subtracting the fraction of the long 3'UTR isoform from the total CD47 mRNA.
Immunoprecipitation of RNA complexes and RT-PCR
GFP-TM-LU, GFP-TM-SU, GFP-TM-HuR-BS and GFP-TM-HuR-BSΔ were transfected into HEK293 cells and immunoprecipitation of protein-RNA complexes was carried out as previously described 37 . RNA-IPs were performed with cross-linking to prevent reassociation of HuR with mRNA after lysis 38 . Briefly, cells were harvested and washed twice in cold PBS. Formaldehyde was added to a final concentration of 1% (v/v) and the cells were incubated at RT for 10 minutes. The reaction was quenched by addition of glycine to a final concentration of 0.25 M and incubated at RT for 5 minutes. Following centrifugation the cell pellet was washed twice in cold PBS and resuspended in RIPA buffer [25 mM Tris-HCl (pH=7.4), 150 mM NaCl, 1% NP-40, 1% Na-deoxycholate, 0.1% SDS, 1 mM EDTA, protease inhibitor cocktail (Roche, 04693124001)]. The mRNPs were solubilized by three rounds of sonication for 15 seconds each in a Misonix Ultrasonic Processor S-4000 at an output of 8-9 W. Insoluble material was removed by centrifugation. Lysates were pre-cleared by addition of magnetic protein A beads (Millipore, LSKMAGA10) and incubation for 30 minutes at 4°C with constant mixing. The pre-cleared lysate was divided into three parts. One portion was retained for the input control and antiHuR (Millipore, 07-1735) or IgG (Santa Cruz, sc-2025) were added to the two other portions and incubated at 4°C for 2 hours. Magnetic protein A beads (Millipore, LSKMAGA10) were added and incubated at 4°C for 1 hour. The beads were washed five times with high stringency RIPA buffer (50 mM Tris-HCl (pH=7.4), 1 M NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, and 1 mM EDTA). The crosslinking was reversed by resuspending the beads in 50 mM Tris-Cl (pH=7.0), 5 mM EDTA, 10 mM DTT and 1% SDS, followed by incubation at 70°C for 45 minutes. RNA was extracted from the beads and buffer using TRI Reagent (Ambion) according to the manufacturer's protocol, and cDNA was synthesized as previously described. qRT-PCR was carried out using primers for GAPDH (see earlier) and GFP, so as not to amplify endogenous CD47. The primers used were as follows: GFPF: 5'-TAAACGGCCACAAGTCAGC-3'; GFPR: 5'-AAGTCGTGCTGCTTCATGTG-3'; HEK293 cells transiently transfected with sh2 HuR or sh Co were used to assess the presence of SET on endogenous CD47 mRNA and the requirement of HuR for this association. Cells were transfected and treated with high dose puromycin for 3 days. FACS analysis was used to ensure greater than 90% of surviving cells expressed the shRNA. RNA-IP was carried out as described above, but using anti-SET (Abcam, ab181990) or IgG (Santa Cruz, sc-2025). The following primers were used for qRT-PCR of CD47-LU: CD47F: 5'-AAGAGAACTCCAGTGTTGCT-3'; CD47R: 5'-ACGGTAACACAGCTGTAAAACA-3'
The obtained CT values were first normalized to GAPDH and then the fraction of input mRNA was plotted.
Western blotting
HEK293 cells stably expressing sh3 HuR, sh4 HuR, sh1 SET, sh2 SET, sh2 Rac1, sh3 Rac1 or sh Co as well HEK293 cells transiently transfected with sh2 HuR, CD47-SU, CD47-LU, CD47-LU+N17Rac1, CD47-LU2Km, CD47-LUΔC or CD47-LUΔCL were lysed in Laemmli buffer (Sigma, S3401), boiled for seven minutes and then cooled on ice. Lysates were run on NuPAGE® Novex 4-12% Bis-Tris Gel (Invitrogen, NP0322BOX) and transferred to PVDF membrane (Bio-rad, 162-0177). After blocking for 1 hour at RT in Odyssey Blocking Buffer (Li-Cor, 927-40000) the following primary antibodies were used: rabbit anti-HuR (Millipore, 07-1735), rabbit anti-SET (Abcam, ab181990), mouse anti-RAC1 (Cell signaling Technology, 8631S), mouse anti-ACTB (Sigma, A4700), rabbit anti-ACTB (Sigma, A2066), chicken anti-GFP (Abcam, ab13970), mouse anti-CD47 (Santa Cruz, sc-59079), mouse anti-CD44 (BD Bioscience, 561858), and rabbit anti-TSPAN13 (GeneTex, GTX52155). The antibodies were diluted in Odyssey Blocking Buffer containing 0.1% Tween 20 and the blots were incubated over night at 4°C. 
Co-Immunoprecipitation
CD47-SU, CD47-LU, CD47-LUΔC and CD47-LUΔCL were transfected into HEK293 cells and the cells were lysed in ice cold RIPA buffer [(25 mM Tris-HCl (pH=7.4), 150 mM NaCl, 1% NP-40, 1% Na-deoxycholate, 0.1% SDS, 1 mM EDTA, protease inhibitor cocktail (Roche, 04693124001)] for 5 minutes on ice. After the cells were spun down at 20,000 x g for 20 minutes the supernatant was pre-cleared as described above. The lysate was divided in two equal parts (a small portion was removed to be used as the input control). Anti-GFP (Invitrogen, A-6455) or IgG (Santa Cruz, sc-2025) was added to the lysates and a 1 hour rocking incubation at 4°C was performed, followed by addition of magnetic protein A beads (Millipore, LSKMAGA10) and another 1 hour rocking incubation at 4°C. Following seven washes in RIPA buffer the beads were then boiled in Laemmli buffer (Sigma, S3401) for seven minutes and then cooled on ice. Western blotting was carried out as described above. Chicken anti-GFP (Abcam, ab13970) antibody was used to confirm immunoprecipitation of GFP constructs and rabbit anti-SET (Abcam, ab181990) antibody was used to assess coimmunoprecipitation of SET protein.
Immunoprecipitation of RAC1-GTP
CD47-SU, CD47-LU and pcDNA 3.1 vector alone were transfected into HEK293 cells. The levels of RAC1-GTP were assessed using an Active Rac1 Detection Kit (Cell Signaling Technology, 8815) following the manufacturer's protocol. Briefly, cells were lysed in ice cold lysis buffer and centrifuged at 16,000 x g for 15 minutes at 4°C. The supernatant was added to GST-PAK1-PBD and glutathione resin and incubated with rocking for 1 hour at 4°C (a small portion was removed to be used as the input control). The resin was washed three times with lysis buffer and then SDS sample buffer was added to elute the bound proteins. Western blotting was carried out as described above. Mouse anti-RAC1 (Cell signaling Technology, 8631S) antibody was used to detect RAC1-GTP as well as to assess total RAC1 in the samples.
Irradiation and cell survival assay
Jurkat, JinB8, and transfected JinB8 cells (24 hours post-transfection) were irradiated for a total of 0, 5, 10, 20 or 40 Gy using a Shepherd Mark-1 cesium irradiator. For JinB8 or Jurkat cells transfected with CD47-LU, CD47-SU or with sh2 CD47-LU the percentage of GFP+ cells was determined by FACS prior to irradiation. Three days after γ-irradiation, cells were stained with TO-PRO3 (Sloan Kettering Institute, Flow Cytometry Core Facility) in FACS buffer A (0.5% FBS in PBS) for 10 minutes at 4°C and analyzed using a BD FACSCalibur cell analyzer to evaluate cell survival. Percent survival was calculated as the TO-PRO3 negative cells divided by the total number of GFP+ cells. Shown are mean and standard deviation of three biological replicates.
Phagocytosis Assay
Human macrophages were obtained by differentiation of THP-1 cells with 25 ng/ml PMA (phorbol 12-myristate 13-acetate, Sigma) for 3 days. On day 3, Jurkat, JinB8, or transfected JinB8 cells were treated with 10 µg/ml Mitomycin C for 2.5 hours at 37°C and washed three times in media. Mitocycin C treatment halts cell division and allows for a more accurate assessment of the percentage of cells that are phagocytosed. For JinB8 cells transfected with CD47-LU or CD47-SU the percentage of GFP+ cells was determined by FACS prior to coculture. The cells were either cultured alone or co-cultured with fully differentiated macrophages. After 3 days, cells were counted and the fraction of GFP+ cells was determined by FACS analysis. The fraction of surviving cells after co-culture with macrophages was normalized by the number of surviving cells without co-culture and is show as mean and standard deviation of three independent experiments. To demonstrate that the cells were phagocytosed, during the last 10 minutes of Mitomycin C treatment the cells were also labeled with CFSE (Carboxyfluorescein succinimidyl ester; Invitrogen). Washing following Mitomycin C and CFSE treatment was carried out in cold media according to the manufacturer's protocol. After co-culture, CFSE uptake by macrophages was measured by FACS analysis to demonstrate that a decrease in the number of surviving cells is due to phagocytosis by macrophages.
Fraction of membrane proteins among HuR target genes
The list of HuR target genes was obtained from previous publications 7, 9 . The union of genes from both publications was analyzed using gene ontology analysis 39 and all genes with the tag "membrane" were considered membrane proteins. This number is consistent with the number of membrane proteins obtained in yeast 40 . Fisher's exact test was used to test for significance.
Statistical analysis
To test for significant differences between samples a two-sided t-test for independent samples was performed using SPSS.
Extended Data
Extended Data Figure 1 . Expression of the long CD47 3'UTR isoform correlates with cell surface expression of CD47 protein (A) Fluorescence confocal microscopy of cells shown as in Fig. 1a . Representative images out of hundreds of cells are shown. Scale bars, 10 µm. (B) FACS analysis of endogenous CD47 expression in cells shown in Fig. 1a and (a) . Permeabilized cells show total CD47 expression (purple) and non-permeabilized cells show Shown is the mean ± s.d., n = 3 biological replicates. The total amount of CD47 mRNA after transfection of sh Co was set to 1. (B) The top construct depicts GFP-TM-SU (Fig. 1e) MS2 ) specifically recognizes these MS2 stem loops. Constructs were generated containing MS2 fused to mC and then either HuR, SET or with no further coding sequence (Fig. 3c) . Co-expression of these constructs with the construct containing the short UTR and MS2-binding sites results in recruitment of SET or HuR to the short 3'UTR of GFP-TM. The cells that express MS2 fused to only mC localize GFP to the endoplasmic reticulum, but constructs containing MS2 fusions to HuR or SET localize GFP primarily to the cell surface ( Fig. 3b and Extended Data Fig. 5c ). Omitting either the MS2 or MS2-binding sites from the experiment abrogates surface localization (Extended Data Fig. 5b, d ). Extended Data Figure 7 . CD47 protein has different functions dependent on whether it was generated by the SU or LU isoform (A) Left, western blot of HEK293 cells after transfection of the indicated constructs shows GFP-CD47 expression using an anti-GFP antibody. Actin was used as loading control. Right, as in left panel after transfection of CD47-SU and CD47-LU into HEK293 (left) or JinB8 cells (right). GFP-CD47 expression was quantified after normalization with respect to Actin using Image J. Shown is the fold-change in GFP-CD47 expression of CD47-SU after setting CD47-LU to 1. 
